Since ETHYLENE RESPONSE FACTOR 11559 and PSEUDO-RESPONSE REGUALATOR 560 are expressed in carpels61 and positively regulate TRN225 expression, those activators and CRC might act antagonistically to control TRN2 expression. The gene discussed is TNPO2; the disease is colorectal carcinoma.